Resistance to DHFR inhibitors can arise through mutations in the DHFR gene or via the expression of alternative enzymes that perform the same function. These mutations may reduce the binding affinity of inhibitors without compromising the enzyme's catalytic activity. Understanding the mechanisms of resistance is crucial for developing new drugs that can effectively target DHFR.
